<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MoleMax Systems</title>
	<atom:link href="https://molemaxsystems.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://molemaxsystems.com/</link>
	<description>Provide the best skin imaging device</description>
	<lastBuildDate>Fri, 02 Oct 2026 10:10:41 +0000</lastBuildDate>
	<language>en-AU</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://molemaxsystems.com/wp-content/uploads/2020/10/favicon.png</url>
	<title>MoleMax Systems</title>
	<link>https://molemaxsystems.com/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </title>
		<link>https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 10:10:41 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[basal cell carcinoma dermoscopy]]></category>
		<category><![CDATA[junctional nevus]]></category>
		<category><![CDATA[melanoma]]></category>
		<category><![CDATA[melanosis]]></category>
		<category><![CDATA[skin lesion evaluation]]></category>
		<category><![CDATA[Spitz naevus]]></category>
		<category><![CDATA[subungual melanoma]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12137</guid>

					<description><![CDATA[<p>A clinical framework for evaluating skin lesions with dermoscopy patterns, pitfalls, and when to biopsy.</p>
<p>The post <a href="https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/">Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Every skin check comes down to one question: is this lesion benign, or does it need action? Reliable skin lesion evaluation is what separates confident practice from guesswork, and dermoscopy is what makes it repeatable  revealing sub-surface structures and vascular patterns that turn subjective pattern recognition into a structured assessment. </p>



<p class="wp-block-paragraph">This guide is an overview: it covers the evaluation framework and several lesion types that don&#8217;t yet have a dedicated deep-dive on this site  junctional nevus vs. melanoma, melanosis, subungual melanoma, and Spitz naevus  and links out to our fuller guides on basal cell carcinoma, acral lesions, the 7-point checklist, and mole mapping where those already exist. </p>



<h2 class="wp-block-heading"><strong>What Skin Lesion Evaluation Involves</strong> </h2>



<p class="wp-block-paragraph">Good skin lesion evaluation combines the clinical picture  history, change over time, and patient risk factors with a magnified dermoscopic view. Dermoscopy adds a second layer of information: pigment network, vessels, colours, and specific structures that correlate with particular diagnoses. The goal is not to replace histology but to decide, with far greater accuracy, which lesions can be reassured, which need monitoring, and which require biopsy. </p>



<h2 class="wp-block-heading"><strong>A Structured Approach to Reading Lesions</strong> </h2>



<p class="wp-block-paragraph">Experienced clinicians rarely assess a lesion at random. A common method is the two-step approach: first decide whether a lesion is melanocytic or non-melanocytic, then apply the relevant criteria for that category. This is followed by pattern analysis weighing symmetry, the regularity of the pigment network, the number of colours, and any melanoma-specific structures. Working through a lesion in this order reduces the chance of anchoring on a single feature and missing the bigger picture. </p>



<h2 class="wp-block-heading"><strong>Junctional Nevus vs. Melanoma</strong> </h2>



<p class="wp-block-paragraph">One of the most common diagnostic questions is junctional nevus vs. melanoma. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td> </td>
<td><strong>Junctional nevus (benign)</strong> </td>
<td><strong>Melanoma</strong> </td>
</tr>
<tr>
<td>Pigment network </td>
<td>Regular, symmetric, even colour </td>
<td>Atypical or broadened, often asymmetric </td>
</tr>
<tr>
<td>Colours </td>
<td>Usually one or two </td>
<td>Often three or more </td>
</tr>
<tr>
<td>Structures </td>
<td>None of concern </td>
<td>Irregular streaks, blue-white structures </td>
</tr>
<tr>
<td>Overall pattern </td>
<td>Symmetric </td>
<td>Asymmetric </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">The overlap between the two is exactly why structured scoring matters. Applying a framework such as the <a href="https://molemaxsystems.com/7-point-checklist-for-melanoma-a-complete-dermoscopy/" target="_blank" rel="noopener">7-Point Checklist for Melanoma</a> helps quantify suspicious features rather than relying on impression alone, and digital monitoring adds the dimension of change over time often the deciding factor for a borderline lesion that looks stable on a single visit. </p>



<h2 class="wp-block-heading"><strong>Melanosis and Pigmented Lesions</strong> </h2>



<p class="wp-block-paragraph">Melanosis and other flat pigmented lesions present their own evaluation challenge, particularly on sun-damaged skin and mucosal surfaces where benign pigmentation and early melanoma can look alike. Dermoscopy helps by revealing whether the pigment follows a regular, structured pattern or an irregular, chaotic one, and whether specific worrying structures are present. </p>



<p class="wp-block-paragraph">Documenting these lesions is especially valuable, because subtle change is often the earliest sign that a stable-looking pigmented area needs review. A baseline image gives the clinician something concrete to compare against at the next visit, rather than relying on memory. </p>



<h2 class="wp-block-heading"><strong>Subungual Melanoma: Reading the Nail</strong> </h2>



<p class="wp-block-paragraph">Few findings cause more anxiety than a pigmented streak in the nail. Subungual melanoma is rare but serious, and it is frequently mistaken for benign melanonychia or a simple haematoma. Dermoscopy of the nail assesses the colour, width, spacing, and regularity of the pigmented band, along with any pigment extending onto the surrounding skin Hutchinson&#8217;s sign, an important warning sign. </p>



<p class="wp-block-paragraph">A widely used screening framework, the ABCDEF rule for subungual melanoma, adds nail-specific criteria age, band breadth and border irregularity, change, digit involved, extension onto skin, and family history — to the general ABCDE approach. Any irregular, broadening, or multicoloured band warrants specialist referral. Cancer Council Australia emphasises that early detection is decisive for melanoma outcomes, and the nail is one site where delayed diagnosis is unfortunately common. When in doubt, referral and biopsy are the safe path. </p>



<h2 class="wp-block-heading"><strong>Spitz Naevus and Other Look-Alikes</strong> </h2>



<p class="wp-block-paragraph">Some benign lesions are notorious for imitating melanoma. Spitz naevus, most common in children and young adults, can show a striking starburst or globular pattern that overlaps with melanoma-specific features. In adults especially, a lesion with spitzoid features is usually excised rather than monitored, because the dermoscopic distinction from melanoma is not reliable enough to justify watchful waiting. Knowing these traps prevents both false reassurance and unnecessary alarm. </p>



<h2 class="wp-block-heading"><strong>Colours Under Dermoscopy and What They Mean</strong> </h2>



<p class="wp-block-paragraph">Colour is one of the most information-rich signals in skin lesion evaluation, because it effectively reports the depth of the pigment. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Colour</strong> </td>
<td><strong>What it indicates</strong> </td>
</tr>
<tr>
<td>Black </td>
<td>Melanin in the upper epidermis </td>
</tr>
<tr>
<td>Brown </td>
<td>Melanin in the deeper epidermis </td>
</tr>
<tr>
<td>Grey or blue </td>
<td>Melanin in the dermis </td>
</tr>
<tr>
<td>Red or pink </td>
<td>Vascularity </td>
</tr>
<tr>
<td>White </td>
<td>Regression or scarring </td>
</tr>
<tr>
<td>Yellow </td>
<td>Keratin or sebaceous material </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">A key rule of thumb: the more colours present in a single lesion, the greater the concern. A uniformly brown lesion is usually reassuring, whereas a lesion showing three or more colours  particularly blue-white or grey  deserves closer scrutiny and, often, biopsy. </p>



<h2 class="wp-block-heading"><strong>Benign Mimics Worth Knowing</strong> </h2>



<p class="wp-block-paragraph">Not every alarming-looking lesion is dangerous. Seborrhoeic keratoses, for example, are extremely common benign lesions that can appear dark and irregular yet show reassuring dermoscopic features  milia-like cysts, comedo-like openings, and a brain-like surface. Recognising these benign patterns confidently is as important as spotting malignant ones: it prevents unnecessary excisions and reassures patients. </p>



<h2 class="wp-block-heading"><strong>Common Pitfalls to Avoid</strong> </h2>



<ul class="wp-block-list">
<li>Relying on a single feature rather than the overall pattern. </li>
</ul>



<ul class="wp-block-list">
<li>Examining a lesion under too much pressure, blanching its vessels and losing the vascular information. </li>
</ul>



<ul class="wp-block-list">
<li>Under-calling amelanotic and nodular melanomas, which lack the classic pigment cues  any firm, growing, or bleeding lesion deserves suspicion regardless of colour. </li>
</ul>



<ul class="wp-block-list">
<li>Failing to document a borderline lesion, which removes the option of comparison later  arguably the most valuable tool a clinician has. </li>
</ul>



<h2 class="wp-block-heading"><strong>Combining the ABCDE Rule with Dermoscopy</strong> </h2>



<p class="wp-block-paragraph">The naked-eye ABCDE rule  Asymmetry, Border irregularity, Colour variation, Diameter over 6mm, and Evolution  remains a useful first filter, especially for patients performing self-examination. Dermoscopy builds on it rather than replacing it: where ABCDE flags a lesion as potentially concerning, dermoscopy interrogates the same lesion at a structural level, confirming or downgrading the suspicion. The two work best together  ABCDE catches the clinician&#8217;s attention, and dermoscopy refines the decision that follows. </p>



<p class="wp-block-paragraph">The &#8220;E&#8221; for evolution deserves particular emphasis, because change over time is the most reliable single indicator of malignancy, and it is precisely what digital documentation captures better than memory ever could. </p>



<h2 class="wp-block-heading"><strong>Basal Cell Carcinoma Dermoscopy</strong> </h2>



<p class="wp-block-paragraph">Basal cell carcinoma dermoscopy is one of the clearest success stories for the technique  arborising vessels, blue-grey ovoid nests, leaf-like areas, and spoke-wheel structures make BCC one of the more recognisable tumours under the dermatoscope, and help distinguish it from benign pink lesions such as intradermal naevi or sebaceous hyperplasia. </p>



<p class="wp-block-paragraph">For the full feature set and how subtype patterns guide treatment choice, see <a href="https://molemaxsystems.com/clinical-and-dermoscopic-characterization-of-mixed-type-basal-cell-carcinoma/" target="_blank" rel="noopener">Clinical and Dermoscopic Characterization of Mixed-Type Basal Cell Carcinoma</a>. </p>



<h2 class="wp-block-heading"><strong>Acral Lesions: Palms and Soles</strong> </h2>



<p class="wp-block-paragraph">Lesions on the palms and soles follow their own dermoscopic rules because of the ridged skin found there: benign acral naevi typically show pigment along the furrows (the parallel-furrow pattern), whereas acral melanoma more often shows pigment on the ridges (the parallel-ridge pattern). </p>



<p class="wp-block-paragraph">For the evidence behind this distinction and the fuller set of acral patterns, see <a href="https://molemaxsystems.com/diagnostic-accuracy-of-dermoscopic-features-in-acral-lentiginous-melanoma/" target="_blank" rel="noopener">Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma</a> and <a href="https://molemaxsystems.com/dermoscopic-features-of-acral-palmoplantar-nevi-age-and-site-correlation-in-a-north-african-cohort/" target="_blank" rel="noopener">Dermoscopic Features of Acral Palmoplantar Nevi</a>. Any irregular or broad pigmentation on these sites still warrants careful assessment regardless of pattern. </p>



<h2 class="wp-block-heading"><strong>Documentation and Monitoring Over Time</strong> </h2>



<p class="wp-block-paragraph">Across every lesion type above, the single biggest advantage of modern practice is the ability to compare images over time. A digital dermoscopy system such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a>, paired with a quality <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite dermatoscope</a>, lets clinicians capture a lesion today and re-examine the exact same site months later. </p>



<p class="wp-block-paragraph">For how total body photography and change tracking fit together, see <a href="https://molemaxsystems.com/mole-mapping-technology-what-it-is-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">Mole Mapping Technology</a>; for how AI-assisted analysis adds a further layer of change detection, see <a href="https://molemaxsystems.com/ai-skin-cancer-detection-system-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">AI Skin Cancer Detection System</a>. </p>



<h2 class="wp-block-heading"><strong>Building Dermoscopy into Routine Practice</strong> </h2>



<p class="wp-block-paragraph">The clinics that get the most from dermoscopy are those that make it routine rather than occasional. Photographing lesions consistently, storing images in a searchable record, and reviewing them at each visit turns a one-off examination into genuine longitudinal care  more than any single feature, that habit drives earlier detection and better outcomes. </p>



<p class="wp-block-paragraph">Skill also grows with reference and repetition. Comparing uncertain lesions against curated image libraries such as Dermoscopedia and DermNet steadily sharpens pattern recognition, and combining that study with a consistent imaging workflow is the fastest way for a clinic to raise the quality of its skin lesion evaluation across every practitioner on the team. </p>



<h2 class="wp-block-heading"><strong>Bring Structure to Your Skin Checks</strong> </h2>



<p class="wp-block-paragraph">The clearest way to see how digital dermoscopy fits your workflow is a live walkthrough. <a href="https://molemaxsystems.com/online-demo-request" target="_blank" rel="noopener">Book a free 15-minute MoleMax demo</a> and our specialist team will show you high-resolution capture, lesion tracking, side-by-side comparison, and structured reporting on real cases  and answer any questions specific to your practice. </p>



<p class="wp-block-paragraph">&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/">Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>DermLite DL5 vs DL4: Which Dermatoscope Should You Choose?</title>
		<link>https://molemaxsystems.com/dermlite-dl5-vs-dl4/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 09:45:19 +0000</pubDate>
				<category><![CDATA[Digital Dermoscopy & Skin Imaging]]></category>
		<category><![CDATA[dermatoscope]]></category>
		<category><![CDATA[dermatoscope australia]]></category>
		<category><![CDATA[DermLite]]></category>
		<category><![CDATA[digital dermoscopy]]></category>
		<category><![CDATA[DL4]]></category>
		<category><![CDATA[DL5]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12143</guid>

					<description><![CDATA[<p>DermLite DL5 vs DL4 compared optics, polarisation, battery, and which one fits your clinic.</p>
<p>The post <a href="https://molemaxsystems.com/dermlite-dl5-vs-dl4/">DermLite DL5 vs DL4: Which Dermatoscope Should You Choose?</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The DermLite range is among the most widely used handheld dermatoscopes in the world, and two models dominate the buying decision: the flagship DL5 and its predecessor, the DL4. Both are excellent instruments, but they suit different needs and budgets. This comparison breaks down the real differences optics, polarisation, UV, battery, and smartphone connectivity so you can choose the right dermatoscope for your clinic with confidence.</p>



<h2 class="wp-block-heading">A Quick Overview</h2>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="1024" height="350" class="wp-image-9951" src="https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-1024x350.png" alt="" srcset="https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-1024x350.png 1024w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-300x103.png 300w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-768x263.png 768w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-1536x525.png 1536w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-600x205.png 600w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21-400x137.png 400w, https://molemaxsystems.com/wp-content/uploads/2026/06/MoleMax-Systems-Website-Banners-1900-x-650-px-21.png 1900w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p class="wp-block-paragraph">The DermLite DL5 is the current-generation flagship: a hybrid dermatoscope with variable polarisation, 365nm UV illumination, and a high-capacity battery. The DermLite DL4 is the proven fourth-generation model lighter, simpler, and more affordable, with the same core 10x optics and hybrid polarised/non-polarised imaging that made DermLite the clinical standard. In short: the DL5 adds capability; the DL4 delivers the essentials at a lower price.</p>



<h2 class="wp-block-heading">Feature Comparison at a Glance</h2>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<th>Feature</th>
<th>DermLite DL5</th>
<th>DermLite DL4</th>
</tr>
<tr>
<td>Generation</td>
<td>Flagship (current)</td>
<td>4th generation</td>
</tr>
<tr>
<td>Magnification</td>
<td>10x</td>
<td>10x</td>
</tr>
<tr>
<td>Polarisation</td>
<td>Variable / super-polarised (scroll through range)</td>
<td>Polarised &amp; non-polarised toggle</td>
</tr>
<tr>
<td>365nm UV</td>
<td>Yes</td>
<td>No</td>
</tr>
<tr>
<td>PigmentBoost</td>
<td>Yes</td>
<td>No</td>
</tr>
<tr>
<td>Torch LED</td>
<td>Yes (high-powered)</td>
<td>No</td>
</tr>
<tr>
<td>Battery</td>
<td>High capacity</td>
<td>Standard</td>
</tr>
<tr>
<td>Smartphone connection</td>
<td>MCC universal connector</td>
<td>Magnetic faceplate connect</td>
</tr>
<tr>
<td>Infection control</td>
<td>Autoclavable plate / IceCap</td>
<td>IceCap system</td>
</tr>
<tr>
<td>Best for</td>
<td>High-volume &amp; advanced dermoscopy</td>
<td>Everyday screening &amp; value</td>
</tr>
</tbody>
</table>
</figure>



<h2 class="wp-block-heading">How the Two Compare, Feature by Feature</h2>



<h3 class="wp-block-heading">Optics and Magnification</h3>



<p class="wp-block-paragraph">Both dermatoscopes offer true 10x magnification the clinical standard for assessing pigment networks, vascular structures, and fine lesion detail. In day-to-day pattern analysis, image quality on both is excellent. The DL5&#8217;s larger optical system and refined illumination give it an edge for demanding work, but a clinician using a DL4 isn&#8217;t missing the fundamentals of good dermoscopy.</p>



<h3 class="wp-block-heading">Polarisation: The Biggest Difference</h3>



<p class="wp-block-paragraph">This is where the two models diverge most. The DL4 switches between two fixed modes polarised light for deeper vascular and structural detail, and non-polarised light with contact fluid for surface features which is already a capable combination for most clinical work. The DL5 replaces that switch with a continuous dial: rather than two fixed settings, you move gradually between polarisation levels, letting you track a feature as it appears and fades between the surface and deeper layers in real time. For clinicians who want that level of control mid-examination, it&#8217;s a meaningful upgrade over toggling between two states. <a href="https://dermoscopedia.org/" target="_blank" rel="noopener">Dermoscopedia</a> has a detailed overview of why polarisation matters clinically for anyone wanting the underlying optics.</p>



<h3 class="wp-block-heading">UV Illumination and PigmentBoost</h3>



<p class="wp-block-paragraph">The DL5 adds built-in 365nm UV illumination, letting you highlight fluorescent structures at full magnification useful for certain infections, pigmentary conditions, and specialised applications. It also includes PigmentBoost, which enhances visualisation of pigmented lesions. The DL4 offers neither. For a general skin-cancer screening clinic, these are a bonus rather than a necessity; for specialists who use them routinely, they can be decisive.</p>



<h3 class="wp-block-heading">Battery Life and Charging</h3>



<p class="wp-block-paragraph">Battery capacity is a practical, easily overlooked factor. In practice, the DL5&#8217;s larger battery means a busy clinic can image patients through a full day with fewer mid-session charges, and it comes with a desktop charging base that doubles as storage between patients. The DL4&#8217;s battery holds up fine for typical screening volumes but will need topping up more often under heavy, back-to-back use. Neither model&#8217;s runtime becomes a real constraint unless your clinic is running high patient volumes most days.</p>



<h3 class="wp-block-heading">Smartphone Connectivity and Documentation</h3>



<p class="wp-block-paragraph">Both models connect to smartphones for image capture, by different means: the DL5 uses a universal MCC connector, while the DL4 uses a magnetic faceplate that attaches directly to compatible phones. Either way, pairing a handheld dermatoscope with a phone is a low-cost route into digital documentation. Clinics that want a more complete solution — stored patient records, side-by-side comparison, and structured reporting often pair a DermLite with a full digital system such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a>.</p>



<h3 class="wp-block-heading">Infection Control</h3>



<p class="wp-block-paragraph">Cross-contamination is an increasing concern in dermoscopy. Both models support DermLite&#8217;s IceCap infection-control system of disposable snap-on caps, and the DL5 adds an autoclavable contact plate. For clinics with strict infection-control protocols, this is a genuine part of the buying decision rather than an afterthought.</p>



<h2 class="wp-block-heading">Making the Buying Decision</h2>



<h3 class="wp-block-heading">Which Should You Choose?</h3>



<p class="wp-block-paragraph">Choose the <strong>DL5</strong> if you want the most capable handheld DermLite available, with variable polarisation, UV, PigmentBoost, and extended battery life and you&#8217;re willing to invest more for that flexibility. It suits high-volume clinics and specialists who push dermoscopy to its limits.</p>



<p class="wp-block-paragraph">Choose the <strong>DL4</strong> if you want a proven, lighter, more affordable dermatoscope that still delivers 10x hybrid imaging for everyday skin checks. Many clinics run DL4 units as reliable workhorses and reserve a DL5 for advanced cases.</p>



<h3 class="wp-block-heading">Price and Value</h3>



<p class="wp-block-paragraph">Budget is often the deciding factor. The DL4 sits at a lower price point, making it an attractive entry into professional-grade dermoscopy for a general practice or a clinic buying several units for multiple rooms. The DL5 commands a premium that reflects its added capabilities variable polarisation, UV, PigmentBoost, and the larger battery.</p>



<p class="wp-block-paragraph">The right way to frame the decision isn&#8217;t &#8220;which is cheaper&#8221; but &#8220;which features will I actually use.&#8221; A clinic that will never use UV fluorescence gains little from paying for it, while a specialist who relies on it daily will find the DL5 well worth the difference. Current pricing for both models is available on their <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">product pages</a>.</p>



<h3 class="wp-block-heading">Portability and Handling</h3>



<p class="wp-block-paragraph">Both instruments are pocket-sized and built for one-handed use, but they feel different in the hand. The DL4 is lighter and more compact, which some clinicians prefer for long screening sessions and mobile or outreach work. The DL5 is slightly larger to accommodate its bigger battery and additional light sources a trade-off that buys capability at a small cost in size. Neither is cumbersome; the choice comes down to personal preference and how the instrument will be used across a typical day.</p>



<h3 class="wp-block-heading">Training and Support</h3>



<p class="wp-block-paragraph">Whichever model you choose, the value you get depends on how confidently your team uses it. DermLite instruments are designed to be intuitive, and the core skills of reading pigment networks, vessels, and structures under polarised and non-polarised light transfer directly between models. If your clinic is new to dermoscopy, pairing the hardware with structured training and access to reference image libraries will accelerate the learning curve far more than any single feature on the spec sheet.</p>



<h2 class="wp-block-heading">Beyond DL5 vs DL4</h2>



<h3 class="wp-block-heading">Where the DL5 Plus Fits</h3>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="432" class="wp-image-9268" src="https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-1024x432.jpg" alt="DermLite dermatoscope lens detail" srcset="https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-1024x432.jpg 1024w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-300x127.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-768x324.jpg 768w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-1536x648.jpg 1536w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-600x253.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB-400x169.jpg 400w, https://molemaxsystems.com/wp-content/uploads/2026/03/DL5PlusB.jpg 1629w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p class="wp-block-paragraph">If you&#8217;re researching this comparison, you may also come across the <strong>DermLite DL5 Plus</strong> it&#8217;s worth knowing this is a distinct, separately priced product, not simply another name for the DL5. If the DL5 Plus is on your shortlist, compare it directly against both models in this guide rather than assuming it slots between them on price or features. The wider <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite dermatoscope range</a> also includes the Lumio series and other models suited to particular workflows.</p>



<h3 class="wp-block-heading">Accessories and the Wider Ecosystem</h3>



<p class="wp-block-paragraph">A dermatoscope is rarely used in isolation. Contact plates (including hair-counting grids and small plates for awkward, concave areas), charging bases, rulers, eyepieces, and infection-control caps all extend what either instrument can do. The DL5&#8217;s autoclavable plate and charging base are geared toward high-throughput clinics, while the DL4&#8217;s lighter accessory set keeps it simple and portable. When budgeting, factor in the accessories your workflow actually needs — they affect both the up-front cost and day-to-day convenience.</p>



<h2 class="wp-block-heading">The Bottom Line</h2>



<p class="wp-block-paragraph">There&#8217;s no universally &#8220;best&#8221; dermatoscope in the DL5 vs. DL4 debate only the best fit for a given clinic. The DL4 remains a superb, cost-effective instrument that covers everything most practitioners need for confident everyday dermoscopy. The DL5 is the choice when you want the fullest feature set, the longest battery life, and the flexibility of variable polarisation and UV. Match the instrument to how you actually work, the patients you see, and the budget you have, and either model will serve your clinic well for years.</p>



<h2 class="wp-block-heading">Frequently Asked Questions</h2>



<p class="wp-block-paragraph"><strong>Is the DL5 worth the extra cost over the DL4?</strong></p>



<p class="wp-block-paragraph">For high-volume clinics and specialists who will use UV, PigmentBoost, and variable polarisation, yes. For routine screening on a budget, the DL4 delivers the essentials at lower cost.</p>



<p class="wp-block-paragraph"><strong>Can both connect to a smartphone?</strong></p>



<p class="wp-block-paragraph">Yes, the DL5 uses a universal MCC connector and the DL4 uses a magnetic faceplate, so both support smartphone image capture for basic documentation.</p>



<p class="wp-block-paragraph"><strong>Do I still need a digital imaging system if I have a DermLite?</strong></p>



<p class="wp-block-paragraph">A handheld dermatoscope is ideal for examining individual lesions, but for stored records, total body mapping, and change tracking, many clinics add a full system such as the MoleMax HD.</p>



<p class="wp-block-paragraph"><strong>Is the DermLite DL5 Plus the same as the DL5?</strong></p>



<p class="wp-block-paragraph">No, the DL5 Plus is a separate, separately priced model. Compare it directly against the DL5 and DL4 rather than assuming where it fits.</p>



<h2 class="wp-block-heading">See the DermLite Range in Action</h2>



<p class="wp-block-paragraph">The best way to choose is to try the technology in your own clinic. <a href="https://molemaxsystems.com/online-demo-request" target="_blank" rel="noopener">Book a free 15-minute MoleMax demo</a>, and our specialist team will help you match the right dermatoscope or imaging system to your workflow, patient volume, and budget.</p>



<p class="wp-block-paragraph">&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/dermlite-dl5-vs-dl4/">DermLite DL5 vs DL4: Which Dermatoscope Should You Choose?</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Trichoscopy Explained: Hair &#038; Scalp Analysis with TrichoScan </title>
		<link>https://molemaxsystems.com/trichoscopy-hair-analysis-trichoscan/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 08:56:00 +0000</pubDate>
				<category><![CDATA[Research & Clinical Evidence]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12140</guid>

					<description><![CDATA[<p>Discover how trichoscopy and TrichoScan provide objective hair and scalp analysis, helping clinicians diagnose hair loss and monitor treatment progress with measurable results.</p>
<p>The post <a href="https://molemaxsystems.com/trichoscopy-hair-analysis-trichoscan/">Trichoscopy Explained: Hair &#038; Scalp Analysis with TrichoScan </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Hair loss is one of the most common reasons patients seek dermatological help, yet it is notoriously difficult to assess objectively by eye. <strong>Trichoscopy</strong>, dermoscopy of the hair and scalp, has transformed this field by making it possible to examine, measure, and monitor hair with real precision. This guide explains what trichoscopy is, how automated tools such as TrichoScan work, and why objective hair analysis matters in modern practice. </p>



<h2 class="wp-block-heading">What Is Trichoscopy? </h2>



<p class="wp-block-paragraph">Trichoscopy is the application of dermoscopy to the scalp and hair. Using magnification and controlled illumination, it lets clinicians examine hair shaft thickness, follicular openings, perifollicular skin, and vascular patterns that are invisible to the naked eye. It has become a first-line, non-invasive tool for diagnosing hair and scalp disorders, often reducing the need for a more invasive scalp biopsy. </p>



<p class="wp-block-paragraph">The technique is valuable because different conditions produce different, recognisable patterns. Androgenetic alopecia, alopecia areata, telogen effluvium, and scarring alopecias each show characteristic trichoscopic features, allowing a more confident diagnosis at the bedside. </p>



<h2 class="wp-block-heading">Why Objective Hair Measurement Matters </h2>



<p class="wp-block-paragraph">The core problem in managing hair loss is measurement. Patients and clinicians alike struggle to judge, by memory or photographs, whether hair is thinning, stable, or regrowing. Subjective assessment is unreliable and slow to show change. Objective <strong>hair density analysis</strong> solves this by turning the scalp into measurable numbers hairs per square centimetre, average shaft thickness, and the ratio of growing to resting hairs that can be tracked over time. </p>



<h2 class="wp-block-heading">How TrichoScan Works </h2>



<p class="wp-block-paragraph">TrichoScan is a trichoscopy software system that combines epiluminescence microscopy with automatic image analysis to measure the biological parameters of hair growth in a single clinical workflow. In practice, a small area of scalp is imaged, and the software automatically counts and characterises the hairs, measuring hair density, hair diameter, and the anagen (growing) to telogen (resting) ratio. Because the analysis is automated, it removes much of the subjectivity and variability of manual counting. </p>



<p class="wp-block-paragraph">The <a href="https://molemaxsystems.com/trichoscan-software/" target="_blank" rel="noopener">TrichoScan Software</a> is used as an add-on within the MoleMax imaging ecosystem and is clinically validated with a high operator-agreement rate. That reproducibility is what makes it suitable not just for diagnosis but for objectively monitoring how a patient responds to treatment over months. </p>



<h2 class="wp-block-heading">Key Parameters Trichoscopy Measures </h2>



<p class="wp-block-paragraph"><strong>Hair density.</strong> The number of hairs per unit area the headline figure for tracking thinning or regrowth. </p>



<p class="wp-block-paragraph"><strong>Hair shaft diameter.</strong> The thickness of individual hairs. Progressive miniaturisation (thinning shafts) is a hallmark of androgenetic alopecia. </p>



<p class="wp-block-paragraph"><strong>Anagen-to-telogen ratio.</strong> The proportion of hairs actively growing versus resting. A shift toward telogen signals increased shedding, as seen in telogen effluvium. </p>



<p class="wp-block-paragraph"><strong>Follicular units.</strong> The number of hairs per follicular unit, another marker of miniaturisation over time. </p>



<h2 class="wp-block-heading">Clinical Uses of Trichoscopy and TrichoScan </h2>



<p class="wp-block-paragraph">The most common application is androgenetic alopecia, male and female pattern hair loss, where objective density and diameter measurements confirm the diagnosis and establish a baseline. Trichoscopy is equally useful for distinguishing scarring from non-scarring alopecias, assessing alopecia areata, and evaluating telogen effluvium. Reference resources such as <a href="https://dermnetnz.org/" target="_blank" rel="noopener">DermNet</a> describe the characteristic trichoscopic patterns for each of these conditions in detail. </p>



<p class="wp-block-paragraph">Beyond diagnosis, the biggest practical value is treatment monitoring. When a patient starts therapy, repeat TrichoScan measurements at intervals show, in hard numbers, whether the treatment is working information that supports better decisions and keeps patients engaged with their care. </p>



<h2 class="wp-block-heading">Trichoscopy in a Skin Imaging Clinic </h2>



<p class="wp-block-paragraph">For clinics already performing digital dermoscopy, adding trichoscopy is a natural extension. The same principles of magnified imaging and structured documentation apply, and a system like the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a> can support both skin and scalp imaging within one workflow. Handheld dermatoscopes from the <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite range</a> can also be used for quick scalp examination, with some models offering hair-counting contact plates. This makes trichoscopy an efficient way to broaden the services a clinic offers without a wholesale change in equipment. </p>



<h2 class="wp-block-heading">A Note on Terminology </h2>



<p class="wp-block-paragraph">Patients and referrers search for this capability in many ways, trichoscan test, trichoscan machine, hair analysis, and trichoscopy among them. Using these natural terms in your patient-facing materials helps the people who need the service actually find it, since the underlying demand, as search data shows, is considerable and, at present, largely underserved. </p>



<h2 class="wp-block-heading">Trichoscopy vs Traditional Methods </h2>



<p class="wp-block-paragraph">Before trichoscopy, clinicians relied on methods that were either crude or invasive. The hair-pull test gives only a rough sense of active shedding. Manual hair counts are tedious and inconsistent. The classic phototrichogram, while informative, is labour-intensive. Scalp biopsy, though sometimes necessary, is invasive and unpopular with patients. Trichoscopy, and automated analysis in particular, offers most of the diagnostic value of these methods non-invasively and in minutes, which is why it has become a first-line approach for hair and scalp assessment. </p>



<h2 class="wp-block-heading">Common Trichoscopic Patterns by Condition </h2>



<p class="wp-block-paragraph">Part of what makes <strong>trichoscopy</strong> so powerful is that conditions produce recognisable signatures. Androgenetic alopecia typically shows hair-diameter diversity (a mix of thick and miniaturised hairs), a higher proportion of single-hair follicular units, and peripilar changes, concentrated over the crown. Alopecia areata characteristically shows exclamation-mark hairs, black dots, and yellow dots. Telogen effluvium shows increased empty follicles and regrowing short hairs without the miniaturisation of androgenetic loss. Scarring alopecias show loss of follicular openings, a key warning sign that prompts urgent management. </p>



<p class="wp-block-paragraph">Recognising these patterns lets a clinician reach a confident diagnosis at the first visit in many cases, and objective measurement then anchors the plan that follows. </p>



<h2 class="wp-block-heading">Setting Up Trichoscopy in Practice </h2>



<p class="wp-block-paragraph">Introducing trichoscopy does not require rebuilding a clinic. At its simplest, a handheld dermatoscope and a consistent technique are enough to begin recognising patterns. Adding an automated system such as <a href="https://molemaxsystems.com/trichoscan-software/" target="_blank" rel="noopener">TrichoScan Software</a> brings reproducible measurement, which is what elevates trichoscopy from a diagnostic aid to a monitoring tool. Standardising the imaging site, lighting, and, where required, preparation of the scalp area ensures that measurements taken months apart are genuinely comparable. </p>



<p class="wp-block-paragraph">Consistency is everything in monitoring. A measurement is only meaningful against a comparable baseline, so establishing a repeatable protocol from the outset is the most important step a clinic can take. </p>



<h2 class="wp-block-heading">The Patient Experience </h2>



<p class="wp-block-paragraph">Trichoscopy also changes the conversation with patients, much as skin dermoscopy does. Being able to show someone a magnified image of their own scalp, and later a set of numbers demonstrating that a treatment is working, is far more persuasive than reassurance alone. That objective feedback improves adherence to treatment and helps set realistic expectations both of which matter in a field where results take months and patient anxiety is common. </p>



<h2 class="wp-block-heading">Limitations to Keep in Mind </h2>



<p class="wp-block-paragraph">Trichoscopy is powerful, but it is not infallible. Automated measurement depends on good technique — consistent imaging site, adequate contrast, and proper preparation of the area and poor image quality produces unreliable numbers. Some overlapping conditions can share trichoscopic features, so findings must always be interpreted alongside the clinical history and examination. And while trichoscopy reduces the need for scalp biopsy, it does not eliminate it entirely; scarring alopecias in particular may still require histology. Treating trichoscopy as a decision-support tool rather than a standalone diagnosis keeps its use appropriately grounded. </p>



<h2 class="wp-block-heading">Combining Trichoscopy with Overall Skin Care </h2>



<p class="wp-block-paragraph">For a clinic, trichoscopy rarely stands alone it complements a broader skin and imaging service. Patients presenting with hair concerns often have other dermatological needs, and a practice already equipped for digital dermoscopy is well placed to offer scalp assessment within the same visit. Integrating hair analysis into an existing imaging workflow spreads the value of the equipment across more of the patient base and positions the clinic as a comprehensive skin-health provider rather than a single-service one. Over time, that breadth is both a clinical and a commercial advantage. </p>



<h2 class="wp-block-heading">The Takeaway </h2>



<p class="wp-block-paragraph">Trichoscopy has turned hair and scalp assessment from an impression into a measurement. It supports faster, more confident diagnosis of common conditions like androgenetic alopecia, and crucially it lets clinicians prove whether treatment is working through objective, repeatable numbers. For a skin-imaging clinic, adding <strong>trichoscopy</strong> is a natural, low-friction way to broaden services, deepen patient trust, and meet a clear and currently underserved demand. The technology exists, the search interest is there, and the clinical case is well established; the remaining step is simply putting it to work. </p>



<h2 class="wp-block-heading">Add Objective Hair Analysis to Your Clinic </h2>



<p class="wp-block-paragraph">The best way to choose is to try the technology in your own clinic. <a href="https://molemaxsystems.com/online-demo-request" data-type="link" data-id="https://molemaxsystems.com/online-demo-request">Book a free 15-minute MoleMax demo</a>, and our specialist team will help you match the right dermatoscope or imaging system to your workflow, patient volume, and budget. </p>



<p class="wp-block-paragraph">&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/trichoscopy-hair-analysis-trichoscan/">Trichoscopy Explained: Hair &#038; Scalp Analysis with TrichoScan </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Eccrine Poroma Dermoscopy: Features, Patterns &#038; Diagnosis </title>
		<link>https://molemaxsystems.com/eccrine-poroma-dermoscopy/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 06:52:18 +0000</pubDate>
				<category><![CDATA[Skin Cancer Detection & Diagnosis]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[amelanotic melanoma]]></category>
		<category><![CDATA[basal cell carcinoma]]></category>
		<category><![CDATA[dermatoscope]]></category>
		<category><![CDATA[DermLite]]></category>
		<category><![CDATA[differential diagnosis]]></category>
		<category><![CDATA[eccrine poroma]]></category>
		<category><![CDATA[pigmented poroma]]></category>
		<category><![CDATA[polymorphous vessels]]></category>
		<category><![CDATA[poroma dermoscopy]]></category>
		<category><![CDATA[vascular pattern]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12131</guid>

					<description><![CDATA[<p>A clinical guide to eccrine poroma dermoscopy vascular patterns, key features, and how to tell it apart from melanoma.</p>
<p>The post <a href="https://molemaxsystems.com/eccrine-poroma-dermoscopy/">Eccrine Poroma Dermoscopy: Features, Patterns &#038; Diagnosis </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Eccrine poroma is benign, but it is one of dermatology&#8217;s most convincing imitators  clinically, it can pass for basal cell carcinoma, pyogenic granuloma, or amelanotic melanoma. Dermoscopy is what separates these at the bedside: the vascular and structural clues it reveals are invisible to the naked eye. This guide covers the dermoscopic features of eccrine poroma, how to examine it correctly, its differential diagnosis, and when imaging should prompt a biopsy rather than reassurance. </p>



<h2 class="wp-block-heading"><strong>At a Glance</strong> </h2>



<p class="wp-block-paragraph"><strong>Quick answer:</strong> Eccrine poroma dermoscopy shows a polymorphous vascular pattern  glomerular, hairpin, and linear-irregular vessels together surrounded by milky-red to white structureless areas and white interlacing haloes. No single feature confirms the diagnosis; it is the combination, read alongside the clinical picture, that distinguishes poroma from BCC, pyogenic granuloma, and amelanotic melanoma. </p>



<h2 class="wp-block-heading"><strong>What Is an Eccrine Poroma?</strong> </h2>



<p class="wp-block-paragraph">An eccrine poroma is a benign adnexal tumour arising from the terminal portion of the sweat-gland duct. It typically presents as a solitary, slow-growing, pink-to-red papule or nodule, most often on the palms, soles, or lower limbs, though it can occur anywhere on the body. Lesions are usually asymptomatic but may bleed easily or feel tender when knocked. </p>



<p class="wp-block-paragraph">Because poromas are predominantly non-pigmented and vascular, they are easily mistaken for other pink lesions, both benign and malignant. That ambiguity is exactly where dermoscopy earns its place: it gives the practitioner objective structural information rather than a judgement based on colour and shape alone. </p>



<h2 class="wp-block-heading"><strong>How to Examine a Suspected Poroma</strong> </h2>



<p class="wp-block-paragraph">A reliable read starts with technique. Both polarised and non-polarised dermoscopy add value: polarised light shows vascular structures and deeper features more clearly, while non-polarised light with contact fluid highlights surface detail. Apply minimal pressure vascular lesions like poroma blanch easily, and their vessels can disappear if the instrument is pressed too firmly, taking the diagnostic information with them. </p>



<p class="wp-block-paragraph">A quality dermatoscope from the <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite range</a> makes it straightforward to switch between polarised and non-polarised modes on the same lesion; examining in both modes routinely surfaces features that a single view can miss. </p>



<h2 class="wp-block-heading"><strong>Dermoscopic Features of Eccrine Poroma</strong> </h2>



<p class="wp-block-paragraph">No single feature is pathognomonic, but several patterns recur and, taken together, point towards the diagnosis. Dermoscopedia lists branched vessels with rounded endings, white interlacing areas, yellow structureless areas, and milky-red globules as the core associated features. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Feature</strong> </td>
<td><strong>Appearance</strong> </td>
<td><strong>Diagnostic note</strong> </td>
</tr>
<tr>
<td>Polymorphous vascular pattern </td>
<td>Glomerular (coiled), hairpin, and linear-irregular vessels within one lesion </td>
<td>One of the most consistent and useful clues </td>
</tr>
<tr>
<td>Milky-red / &#8220;cherry-blossom&#8221; areas </td>
<td>Pink-white to milky-red structureless zones surrounding the vessels </td>
<td>Reflects the tumour&#8217;s rich blood supply and oedematous stroma </td>
</tr>
<tr>
<td>White interlacing areas and haloes </td>
<td>Pale, white, interlacing bands or haloes around vessels </td>
<td>Helps distinguish poroma from purely malignant vascular lesions </td>
</tr>
<tr>
<td>Yellowish structureless zones </td>
<td>Yellow, structureless areas with a well-demarcated border </td>
<td>Corresponds to the tumour&#8217;s histological architecture </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">These patterns are documented in detail by Lallas et al. in their widely cited paper, <em>&#8220;Eccrine poroma: the great dermoscopic imitator&#8221;</em> (<em>J Eur Acad Dermatol Venereol</em>, 2016) a useful reference when building a mental image library for these lesions. </p>



<h3 class="wp-block-heading"><strong>Why Vascular Patterns Matter More Than Pigment</strong> </h3>



<p class="wp-block-paragraph">Because poromas are non-pigmented far more often than not, the usual pigment-based melanoma criteria offer little help here. The diagnosis instead rests on reading vessel morphology and distribution which is why a careful, low-pressure examination under polarised light matters so much. Training the eye to distinguish glomerular from hairpin from arborising vessels is the single most valuable skill for assessing these lesions. </p>



<p class="wp-block-paragraph">The dermoscopic patterns are not arbitrary: they mirror the underlying histology. The rich, polymorphous vessels correspond to the tumour&#8217;s prominent vascular stroma, while the milky-red and white areas reflect its characteristic cellular islands and surrounding tissue. Understanding this correlation builds confidence in reading the image, and explains why a poroma looks so vascular under the dermatoscope in the first place. </p>



<p class="wp-block-paragraph"><strong>Vessel types at a glance:</strong> </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Vessel pattern</strong> </td>
<td><strong>What it looks like</strong> </td>
</tr>
<tr>
<td>Glomerular </td>
<td>Tightly coiled, ball-like vessels </td>
</tr>
<tr>
<td>Hairpin </td>
<td>Looped vessels with a U-turn, often with a white halo </td>
</tr>
<tr>
<td>Linear-irregular </td>
<td>Straight or slightly curved vessels of uneven calibre </td>
</tr>
<tr>
<td>Arborising (BCC clue, not poroma) </td>
<td>Branching, tree-like vessels with decreasing calibre </td>
</tr>
</tbody>
</table>
</figure>



<h2 class="wp-block-heading"><strong>Differential Diagnosis and When to Biopsy</strong> </h2>



<h3 class="wp-block-heading"><strong>What Poroma Can Mimic</strong> </h3>



<p class="wp-block-paragraph">The reason clinicians reach for the dermatoscope is that a poroma can imitate lesions with very different implications. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Mimic</strong> </td>
<td><strong>Distinguishing dermoscopic clue</strong> </td>
</tr>
<tr>
<td>Basal cell carcinoma </td>
<td>Classically shows arborising vessels and other BCC-specific structures, rather than poroma&#8217;s polymorphous mix </td>
</tr>
<tr>
<td>Amelanotic melanoma (critical exclusion) </td>
<td>May show atypical polymorphous vessels; demands a low threshold for biopsy whenever present </td>
</tr>
<tr>
<td>Pyogenic granuloma </td>
<td>Often a single dominant vascular pattern rather than poroma&#8217;s polymorphous mix, with a collarette and rapid growth history </td>
</tr>
<tr>
<td>Squamous cell carcinoma </td>
<td>Looks for keratin, white circles, and different vessel morphology against a background of sun damage </td>
</tr>
<tr>
<td>Irritated seborrhoeic keratosis </td>
<td>Comedo-like openings and milia-like cysts typical of keratosis, rather than a vascular-dominant picture </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">When malignancy cannot be confidently excluded, structured criteria such as those in our <a href="https://molemaxsystems.com/7-point-checklist-for-melanoma-a-complete-dermoscopy/" target="_blank" rel="noopener">7-Point Checklist for Melanoma</a> and prompt histology remain essential. Dermoscopy narrows the differential; it does not eliminate the need for biopsy in genuinely uncertain lesions. </p>



<h3 class="wp-block-heading"><strong>When to Biopsy</strong> </h3>



<p class="wp-block-paragraph">A practical rule: dermoscopy should increase, never replace, clinical caution. If a lesion shows classic poroma features and a benign history, monitoring with documented imaging is reasonable. But any lesion with atypical vessels, rapid change, ulceration, or an uncertain read warrants excision and histology. Because amelanotic melanoma sits in this differential, erring toward biopsy when in doubt is the safe course. </p>



<h2 class="wp-block-heading"><strong>Documenting a Poroma for Follow-Up</strong> </h2>



<p class="wp-block-paragraph">For a lesion as ambiguous as poroma, documentation is as valuable as the initial read. A handheld dermatoscope from the DermLite range gives the magnified, polarised view needed to assess vascular patterns, while a digital system such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a> captures and stores that image so the lesion can be monitored, compared over time, or reviewed by a colleague. Recording the dermoscopic appearance also strengthens the clinical record if the lesion later changes or is excised. </p>



<h2 class="wp-block-heading"><strong>Poroma&#8217;s Clinical Spectrum</strong> </h2>



<h3 class="wp-block-heading"><strong>The Poroid Tumour Family</strong> </h3>



<p class="wp-block-paragraph">Poroma is not a single, uniform entity. It belongs to a family of poroid tumours that also includes hidroacanthoma simplex, dermal duct tumour, and poroid hidradenoma, each with its own histological emphasis but overlapping clinical and dermoscopic features. Recognising that these variants exist helps explain why the dermoscopic picture can vary from one lesion to the next, and why the diagnosis is ultimately confirmed on histology rather than on dermoscopy alone. </p>



<h3 class="wp-block-heading"><strong>Pigmented Poroma: A Diagnostic Trap</strong> </h3>



<p class="wp-block-paragraph">Most poromas are pink and vascular, but a minority are pigmented observational studies report pigmentation in roughly 17% of cases. These darker lesions are the most treacherous, because they can closely resemble melanoma or pigmented basal cell carcinoma on both clinical and dermoscopic examination. Pigmented poromas may show blue-grey or brown structures alongside the usual vascular patterns, and this combination should lower the clinician&#8217;s threshold for biopsy considerably. When pigment enters the picture, the safest assumption is that the lesion needs histological confirmation. </p>



<p class="wp-block-paragraph">This is a good example of why dermoscopy is best understood as a triage tool. It sorts lesions into &#8220;confidently benign,&#8221; &#8220;confidently in need of excision,&#8221; and &#8220;uncertain&#8221; and it is the uncertain group, where pigmented poroma often sits, that benefits most from documented imaging and specialist review. </p>



<h2 class="wp-block-heading"><strong>Key Takeaways</strong> </h2>



<ul class="wp-block-list">
<li>Eccrine poroma is benign but a frequent mimic of malignant lesions, so it deserves careful assessment. </li>
</ul>



<ul class="wp-block-list">
<li>A polymorphous vascular pattern, milky-red areas, and white haloes are the most useful dermoscopic clues none is definitive alone. </li>
</ul>



<ul class="wp-block-list">
<li>The critical exclusions are amelanotic melanoma and basal cell carcinoma. </li>
</ul>



<ul class="wp-block-list">
<li>Any atypical, pigmented, ulcerated, or rapidly changing lesion should be biopsied. </li>
</ul>



<ul class="wp-block-list">
<li>Dermoscopy should sharpen clinical judgement, not override it; documenting the lesion with digital imaging protects both patient and practitioner over time. </li>
</ul>



<p class="wp-block-paragraph">For clinicians building their dermoscopy skills, poroma is a useful teaching lesion precisely because it forces attention onto vascular reading rather than pigment a skill that pays off across the whole spectrum of non-pigmented tumours. Dermoscopedia and DermNet offer extensive image libraries for comparison as you develop that eye. </p>



<h2 class="wp-block-heading"><strong>Frequently Asked Questions</strong> </h2>



<p class="wp-block-paragraph"><strong>What is poroma dermatoscopia (poroma dermoscopy)?</strong>  </p>



<p class="wp-block-paragraph">It&#8217;s the dermoscopic examination of an eccrine poroma using a dermatoscope to reveal the lesion&#8217;s vascular pattern and surface structures, which are not visible to the naked eye and help distinguish it from malignant look-alikes. </p>



<p class="wp-block-paragraph"><strong>Is poroma ecrino the same as eccrine poroma?</strong>  </p>



<p class="wp-block-paragraph">Yes, <em>poroma ecrino</em> is the Spanish term for eccrine poroma, a benign tumour of the sweat-gland duct. </p>



<p class="wp-block-paragraph"><strong>Can dermoscopy alone confirm eccrine poroma?</strong>  </p>



<p class="wp-block-paragraph">No. Dermoscopy narrows the differential and raises or lowers suspicion, but histology is required for definitive diagnosis, particularly when any atypical or pigmented feature is present. </p>



<p class="wp-block-paragraph"><strong>What is the most important feature to rule out on dermoscopy?</strong>  </p>



<p class="wp-block-paragraph">Ruling out amelanotic melanoma is the priority atypical polymorphous vessels or any diagnostic uncertainty should lower the threshold for biopsy. </p>



<p class="wp-block-paragraph"><strong>Are all eccrine poromas pink?</strong> No. Most are pink and vascular, but pigmented variants occur in roughly 17% of cases and carry a higher risk of being mistaken for melanoma or pigmented basal cell carcinoma. </p>



<h2 class="wp-block-heading"><strong>See Dermoscopic Imaging in Practice</strong> </h2>



<p class="wp-block-paragraph"><a href="https://molemaxsystems.com/online-demo-request" target="_blank" rel="noopener">Book a free 15-minute MoleMax demo</a> and our specialist team will show you high-resolution capture, lesion tracking, side-by-side comparison, and structured reporting on real cases — and answer any questions specific to your practice. </p>



<p class="wp-block-paragraph">&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/eccrine-poroma-dermoscopy/">Eccrine Poroma Dermoscopy: Features, Patterns &#038; Diagnosis </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Skin Cancer Detection Devices: A Clinic Buyer&#8217;s Guide to Screening Equipment (2026) </title>
		<link>https://molemaxsystems.com/skin-cancer-detection-devices/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 04:20:14 +0000</pubDate>
				<category><![CDATA[Digital Dermoscopy & Skin Imaging]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AI skin cancer detection]]></category>
		<category><![CDATA[dermatoscope]]></category>
		<category><![CDATA[digital dermoscopy]]></category>
		<category><![CDATA[Skin Cancer Detection Devices: A Clinic Buyer's Guide (2026) skin cancer detection device]]></category>
		<category><![CDATA[total body photography]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12122</guid>

					<description><![CDATA[<p>A clinic buyer's guide to skin cancer detection devices categories, buying criteria, and where MoleMax fits.</p>
<p>The post <a href="https://molemaxsystems.com/skin-cancer-detection-devices/">Skin Cancer Detection Devices: A Clinic Buyer&#8217;s Guide to Screening Equipment (2026) </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Melanoma diagnosed at the earliest stage has a five-year relative survival rate of around 99%; once it has spread to distant sites, that figure falls to roughly 26%. The gap between those two numbers is why clinics invest in dedicated screening equipment rather than relying on the naked eye alone. </p>



<p class="wp-block-paragraph">This guide is a buying and equipment guide: it compares the categories of skin cancer detection devices on the market, what to evaluate before purchasing, and where the MoleMax range fits. It intentionally does not re-explain how AI lesion analysis works step by step for that mechanism see our in-depth explainer, <a href="https://molemaxsystems.com/ai-skin-cancer-detection-system-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">AI Skin Cancer Detection System: How It Works and Why Clinics Are Adopting It</a>. </p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" class="wp-image-11651" src="https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-1024x683.jpg" alt="MoleMax Lite" srcset="https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-1024x683.jpg 1024w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-300x200.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-768x512.jpg 768w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-1536x1024.jpg 1536w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-2048x1365.jpg 2048w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-900x600.jpg 900w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-600x400.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2026/08/DSC01838-Edit-400x267.jpg 400w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>What Counts as a Skin Cancer Detection Device</strong> </h2>



<p class="wp-block-paragraph">Three equipment families cover most clinical use: </p>



<ul class="wp-block-list">
<li><strong>Handheld dermatoscopes</strong> magnify and illuminate a single lesion for immediate visual assessment. They capture nothing automatically unless paired with a camera or phone. </li>
</ul>



<ul class="wp-block-list">
<li><strong>Digital dermoscopy systems</strong> capture, store and track images across visits, turning a one-off look into a longitudinal record. </li>
</ul>



<ul class="wp-block-list">
<li><strong>Point-of-care adjunctive devices</strong> use a non-imaging technology spectroscopy or impedance measurement rather than a photograph, to score a single lesion&#8217;s risk at the point of contact. </li>
</ul>



<p class="wp-block-paragraph">Most dermatology clinics combine the first two. The third category is newer and sits mainly in primary care; the section below places it in context. </p>



<h2 class="wp-block-heading"><strong>The Device Landscape, by Category</strong> </h2>



<figure class="wp-block-image size-full"><img decoding="async" width="600" height="400" class="wp-image-9178" src="https://molemaxsystems.com/wp-content/uploads/2026/02/DL4_1-scaled-1-edited.jpg" alt="DermLite handheld dermatoscope" srcset="https://molemaxsystems.com/wp-content/uploads/2026/02/DL4_1-scaled-1-edited.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2026/02/DL4_1-scaled-1-edited-300x200.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2026/02/DL4_1-scaled-1-edited-400x267.jpg 400w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<p class="wp-block-paragraph">Knowing where a product sits in the wider market helps when a demo or a sales conversation starts comparing systems. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Category</strong> </td>
<td><strong>What it does</strong> </td>
<td><strong>Regulatory note</strong> </td>
<td><strong>Example products</strong> </td>
</tr>
<tr>
<td>Handheld dermatoscope </td>
<td>Magnifies and illuminates one lesion; no storage on its own </td>
<td>General-purpose optical instrument </td>
<td>DermLite range </td>
</tr>
<tr>
<td>Digital dermoscopy / total body system </td>
<td>Captures, stores and tracks images across visits; some add AI-assisted scoring </td>
<td>Varies by market and software claims </td>
<td>MoleMax HD, MoleMax HD PRO, FotoFinder, Canfield Scientific </td>
</tr>
<tr>
<td>Point-of-care adjunctive device </td>
<td>Scores a single lesion using spectroscopy or impedance rather than a stored photograph; used as a rule-out aid, not a diagnosis </td>
<td>FDA-cleared examples exist for primary care use (e.g., DermaSensor, cleared for use by non-specialists; MelaFind and NeviSense were earlier cleared devices in this category) </td>
<td>DermaSensor, MelaFind, NeviSense </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">These adjunctive devices are built for a different setting primary care triage of a single concerning lesion rather than the ongoing, whole-body monitoring that a dermatology or skin-cancer clinic typically needs. For a deeper comparison of AI-based melanoma detection systems, accuracy figures and limitations, see our <a href="https://molemaxsystems.com/ai-melanoma-detection-system-for-clinics-a-2026-guide/" target="_blank" rel="noopener">AI Melanoma Detection System for Clinics: A 2026 Guide</a>. </p>



<h2 class="wp-block-heading"><strong>Total Body vs. Single-Lesion Imaging, in Brief</strong> </h2>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" class="wp-image-9838" src="https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-1024x683.jpg" alt="molemax system lite " srcset="https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-1024x683.jpg 1024w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-300x200.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-768x512.jpg 768w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-1536x1024.jpg 1536w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-2048x1365.jpg 2048w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-900x600.jpg 900w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-600x400.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2026/05/PSKY5454-Edit-400x267.jpg 400w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p class="wp-block-paragraph">Single-lesion dermoscopy zooms in on one spot; total body photography records the whole skin surface so new or changing lesions stand out at a glance on the next visit. Most well-equipped clinics run both, linking an overview image to a detailed dermoscopic capture of anything worth a closer look. </p>



<p class="wp-block-paragraph">For the full mechanics of mole mapping, total body photography, dermoscopy and change tracking together, see <a href="https://molemaxsystems.com/mole-mapping-technology-what-it-is-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">Mole Mapping Technology: What It Is, How It Works, and Why Clinics Are Adopting It</a>. </p>



<h2 class="wp-block-heading"><strong>Where the MoleMax Range Fits</strong> </h2>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Product</strong> </td>
<td><strong>Category</strong> </td>
<td><strong>Best fit</strong> </td>
</tr>
<tr>
<td><a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite dermatoscopes</a> </td>
<td>Handheld dermatoscope </td>
<td>First purchase for a clinic new to dermoscopy, or occasional single-lesion checks </td>
</tr>
<tr>
<td><a href="https://molemaxsystems.com/lite/" target="_blank" rel="noopener">MoleMax Lite</a> </td>
<td>Digital dermoscopy, entry-level </td>
<td>Clinics wanting digital capture without a full total-body setup, with room to upgrade later </td>
</tr>
<tr>
<td><a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a> </td>
<td>Digital dermoscopy, full system </td>
<td>Clinics screening regularly, needing lesion scoring and structured reporting </td>
</tr>
<tr>
<td><a href="https://molemaxsystems.com/product-molemax-hd-pro/" target="_blank" rel="noopener">MoleMax HD PRO</a> </td>
<td>Digital dermoscopy with motorised total body mapping </td>
<td>High-volume skin-cancer clinics running full-body baseline and follow-up imaging </td>
</tr>
<tr>
<td><a href="https://molemaxsystems.com/trichoscan-digital-hair-analysis-for-modern-dermatology/" target="_blank" rel="noopener">TrichoScan</a> </td>
<td>Specialised imaging </td>
<td>Scalp and hair density assessment — outside lesion detection, but built on the same image-analysis approach </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">A practice can start with a MoleMax Lite and move up to a MoleMax HD or HD PRO as patient volume and total-body-mapping needs grow, without discarding the initial investment. </p>



<h2 class="wp-block-heading"><strong>What to Evaluate Before Buying</strong> </h2>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Factor</strong> </td>
<td><strong>Questions to ask</strong> </td>
</tr>
<tr>
<td>Image quality </td>
<td>Resolution, polarised vs. non-polarised capture, consistency of lighting across sessions </td>
</tr>
<tr>
<td>Change tracking </td>
<td>Can the software place two visits&#8217; images side by side automatically, or does staff do this manually? </td>
</tr>
<tr>
<td>Reporting </td>
<td>Does it generate a structured, patient-ready report linked to the patient record? </td>
</tr>
<tr>
<td>Regulatory status </td>
<td>Is the device/software cleared or registered for its claimed use in your market (e.g., TGA in Australia, FDA in the US)? </td>
</tr>
<tr>
<td>Total cost of ownership </td>
<td>Upfront hardware cost, software licensing, any recurring subscription fee, and support/training cost </td>
</tr>
<tr>
<td>Training and support </td>
<td>Onsite or remote training included; typical time for staff to reach confident daily use </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">On cost: not every system in this category charges a subscription  confirm this specifically, since it materially changes total cost of ownership over a 3–5 year horizon, not just the headline price. </p>



<h2 class="wp-block-heading"><strong>Why This Matters for Outcomes</strong> </h2>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" class="wp-image-9174" src="https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-1024x683.jpg" alt="Skin examination with dermatoscope" srcset="https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-1024x683.jpg 1024w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-300x200.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-768x512.jpg 768w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-900x600.jpg 900w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-600x400.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited-400x267.jpg 400w, https://molemaxsystems.com/wp-content/uploads/2026/02/blo1-2-edited.jpg 1100w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p class="wp-block-paragraph"><a href="https://www.canceraustralia.gov.au/cancer-types/melanoma-skin/melanoma-skin-statistics" target="_blank" rel="noopener">Cancer Australia</a> reports an overall 94% five-year relative survival rate for melanoma diagnosed in 2017–2021. Survival varies sharply by stage at diagnosis: <a href="https://www.cancer.org.au/about-us/policy-and-advocacy/prevention/uv-radiation/related-resources/skin-cancer-incidence-and-mortality" target="_blank" rel="noopener">Cancer Council Australia</a> cites close to 100% five-year survival for Stage I melanoma, falling to roughly 26% for Stage IV. The <a href="https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma" target="_blank" rel="noopener">American Academy of Dermatology</a> similarly recommends regular skin self-exams and professional skin checks as central to catching melanoma while it is still thin and localised. </p>



<p class="wp-block-paragraph">Digital monitoring doesn&#8217;t replace clinical judgement, but it directly supports this stage-at-diagnosis effect: a stored image history makes a slow-changing lesion visible months before it would otherwise prompt a visit. For how AI-assisted systems perform against dermatologists of varying experience in realistic settings, including the gap between expert and novice readers, see our clinical-evidence review, <a href="https://molemaxsystems.com/limits-of-artificial-intelligence-models-for-skin-cancer-diagnosis-in-realistic-settings/" target="_blank" rel="noopener">Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings</a>. </p>



<h2 class="wp-block-heading"><strong>Fitting a Device Into the Clinic Day</strong> </h2>



<p class="wp-block-paragraph">A typical rollout: capture a baseline full-body image set at a patient&#8217;s first skin check, dermoscopically image any lesion of concern, then schedule a follow-up so the same lesions are re-examined and compared automatically. With proper training, most clinics integrate digital dermoscopy within a few weeks, and the documentation time saved tends to offset the learning curve quickly. </p>



<p class="wp-block-paragraph">Being able to show a patient a magnified image of their own lesion and explain what&#8217;s being monitored and why also improves follow-up attendance, which matters as much for outcomes as the imaging itself. </p>



<h2 class="wp-block-heading"><strong>Common Procurement Questions</strong> </h2>



<p class="wp-block-paragraph"><strong>Do I need a full digital dermoscopy system, or is a dermatoscope enough?</strong> For occasional checks, a handheld dermatoscope is usually enough. Clinics screening regularly, or monitoring high-risk patients over time, get the most value from digital capture with change tracking. </p>



<p class="wp-block-paragraph"><strong>Is a subscription required?</strong> Not with every system. Some digital dermoscopy platforms, including the MoleMax range, are offered without ongoing subscription fees. Confirm this before comparing headline prices, since it changes the multi-year cost picture considerably. </p>



<p class="wp-block-paragraph"><strong>Can I start small and upgrade later?</strong> Yes, within the same product family, a MoleMax Lite deployment can move to a MoleMax HD or HD PRO as volume grows, without re-doing the initial setup. </p>



<p class="wp-block-paragraph"><strong>How long does staff training take?</strong> Most clinics report confident daily use within a few weeks of onsite or remote training; exact timing depends on how much the team documents today versus on paper. </p>



<p class="wp-block-paragraph"><strong>Does total body mapping require a dedicated room?</strong> The motorised total-body-mapping stand used with systems like the MoleMax HD PRO needs a fixed, consistent-lighting space; a lighter dermoscopy-only setup does not. </p>



<h2 class="wp-block-heading"><strong>See It in Your Own Workflow</strong> </h2>



<p class="wp-block-paragraph"><a href="https://molemaxsystems.com/online-demo-request" target="_blank" rel="noopener">Book a free 15-minute MoleMax demo</a> to see high-resolution capture, lesion tracking, side-by-side comparison and structured reporting on real cases, and get your specific procurement questions answered. </p>



<p class="wp-block-paragraph">&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/skin-cancer-detection-devices/">Skin Cancer Detection Devices: A Clinic Buyer&#8217;s Guide to Screening Equipment (2026) </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>UK consortium targets safer dermatology AI</title>
		<link>https://molemaxsystems.com/uk-consortium-targets-safer-dermatology-ai/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 00:40:56 +0000</pubDate>
				<category><![CDATA[Research & Clinical Evidence]]></category>
		<category><![CDATA[dematology research]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12087</guid>

					<description><![CDATA[<p>The new independent group will evaluate artificial intelligence tools used in dermatology, aiming to generate real-world evidence on safety, effectiveness, and clinical performance before wider NHS adoption.</p>
<p>The post <a href="https://molemaxsystems.com/uk-consortium-targets-safer-dermatology-ai/">UK consortium targets safer dermatology AI</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6abfd9861644b"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row top-level"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p>A new UK consortium has been established to independently evaluate artificial intelligence technologies in dermatology, with its clinical leaders saying the initiative could help inform AI assurance frameworks internationally as health systems, including Australia’s, grapple with the safe adoption of diagnostic AI.</p>
<p>The British Association of Dermatologists (BAD) launched the Skin and Responsible Artificial Intelligence (SkinRAI) Consortium at its 106th Annual Meeting in Manchester.</p>
<p>The clinically led initiative will assess whether AI tools used in dermatology are safe, effective, equitable, and clinically useful before they are implemented more widely across the NHS.</p>
<p data-autoattached="true">The launch follows recommendations from the National Commission into the Regulation of AI in Healthcare, which called for trusted datasets, real-world evidence, ongoing evaluation, and post-market monitoring to underpin safe AI adoption.</p>
<p data-autoattached="true">To read more on this article please <a href="https://www.dermatologyrepublic.com.au/uk-consortium-targets-safer-dermatology-ai/2658?utm_source=MC-Dermatology%20Republic%20Master%20List&amp;utm_campaign=UK%20dermatology%20AI%20watchdog%20to%20have%20global%20impact&amp;utm_medium=email&amp;utm_content=UK%20dermatology%20AI%20watchdog%20to%20have%20global%20impact&amp;utm_term=UK%20consortium%20targets%20safer%20dermatology%20AI-headline&amp;mc_cid=e2f7a22a5f&amp;mc_eid=2667407b2b" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<p>The post <a href="https://molemaxsystems.com/uk-consortium-targets-safer-dermatology-ai/">UK consortium targets safer dermatology AI</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Landmark moment for adjuvant melanoma treatment</title>
		<link>https://molemaxsystems.com/landmark-moment-for-adjuvant-melanoma-treatment/</link>
		
		<dc:creator><![CDATA[Karen Hanni]]></dc:creator>
		<pubDate>Wed, 16 Sep 2026 06:25:02 +0000</pubDate>
				<category><![CDATA[Evidence & Research]]></category>
		<category><![CDATA[dematology research]]></category>
		<category><![CDATA[melanoma]]></category>
		<category><![CDATA[skin cancer]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11995</guid>

					<description><![CDATA[<p>MSD and Moderna have announced a positive outcome for their phase 3 trial comparing an investigational and individualised mRNA vaccine with anti-PD-1 therapy in melanoma patients.</p>
<p>The post <a href="https://molemaxsystems.com/landmark-moment-for-adjuvant-melanoma-treatment/">Landmark moment for adjuvant melanoma treatment</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6abfd98617fd3"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p>Pharmaceutical companies MSD and Moderna have announced a positive outcome for their phase 3 trial comparing an investigational and individualised mRNA vaccine with anti-PD-1 therapy in melanoma patients.</p>
<p>The combination of intismeran autogene and pembrolizumab (Keytruda) was found to result in “statistically significant and clinically meaningful improvements” in recurrence-free survival and distant metastasis-free survival compared to pembrolizumab alone – although no actual data were presented.</p>
<p>“This represents the first positive phase 3 readout for an individualized neoantigen therapy and for an mRNA-based cancer therapy, as well as the first phase 3 study to demonstrate a clinically meaningful improvement over Keytruda alone, a standard-of-care immunotherapy, in the adjuvant setting for patients with resected melanoma,” said MSD and Moderna in a joint statement.</p>
<p>To read the full article please <a href="https://www.dermatologyrepublic.com.au/landmark-moment-for-adjuvant-melanoma-treatment-long/2819?utm_source=MC-*|LIST:NAME|*&amp;utm_campaign=*|MC:SUBJECT|*&amp;utm_medium=email&amp;utm_content=*|MC:SUBJECT|*&amp;utm_term=%E2%80%98Landmark%20moment%20for%20adjuvant%20melanoma%20treatment%E2%80%99%3A%20Long-headline&amp;mc_cid=d0287b79f9&amp;mc_eid=2667407b2b" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<p>The post <a href="https://molemaxsystems.com/landmark-moment-for-adjuvant-melanoma-treatment/">Landmark moment for adjuvant melanoma treatment</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>A comprehensive preoperative decision-making  tool for optimal surgical closure: CHAIRS</title>
		<link>https://molemaxsystems.com/a-comprehensive-preoperative-decision-making-tool-for-optimal-surgical-closure-chairs/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Thu, 10 Sep 2026 01:28:52 +0000</pubDate>
				<category><![CDATA[Skin Cancer Research & Evidence]]></category>
		<category><![CDATA[dermatology research]]></category>
		<category><![CDATA[skin cancer]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11973</guid>

					<description><![CDATA[<p>The process of excising and repairing skin cancers has the potential to be highly complex. This is especially the case on the head and neck or where a complex closure is required.</p>
<p>The post <a href="https://molemaxsystems.com/a-comprehensive-preoperative-decision-making-tool-for-optimal-surgical-closure-chairs/">A comprehensive preoperative decision-making  tool for optimal surgical closure: CHAIRS</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6abfd98619806"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p><strong>Jeremy Hay, Clara Jimenez Balcells, Charles Ayesa</strong></p>
<p><strong>Background</strong><br />
The process of excising and repairing skin cancers has the potential to be highly complex. This is especially the case on the head and neck or where a complex closure is required. To optimise decision making, it is important that at the planning stage all of the various, potentially competing, considerations are made explicit and appropriately ranked in relation to the four surgical hierarchical goals which are:<br />
(1) curing the cancer; (2) avoiding functional disturbance; (3) avoiding complications; and (4) achieving good cosmesis.</p>
<p><strong>Objective</strong><br />
We wished to design an easily remembered formal process that would not only assist doctors ensure they had considered all the relevant variables but that would also help rank these in terms of surgical importance prior to making a surgical plan. An appropriate acronym is an efficient means of ensuring the most important considerations are made explicit first (establishing the hierarchy) and that all the relevant information is gathered. Only then does the solution phase proceed. This is the basis of ‘CHAIRS’ which stands for: Cure the Cancer; Hole; Area/Alignment; Icebergs/Incidents; Reservoirs; Solution(s)/Salvage.</p>
<p><strong>Discussion</strong><br />
CHAIRS enables structured, orderly preoperative planning crucial for achieving favourable outcomes in skin cancer surgery. It provides less experienced doctors a framework to work with, and more experienced ones with a back-up first principles approach. It is easy to learn, remember and teach.</p>
<p>To read more on this article please <a href="https://www1.racgp.org.au/getattachment/35919a4f-dd75-4998-8a98-6f286f8a3dd9/A-comprehensive-preoperative-decision-making-tool.aspx" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<p>The post <a href="https://molemaxsystems.com/a-comprehensive-preoperative-decision-making-tool-for-optimal-surgical-closure-chairs/">A comprehensive preoperative decision-making  tool for optimal surgical closure: CHAIRS</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</title>
		<link>https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Thu, 20 Aug 2026 00:04:44 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[dematology research]]></category>
		<category><![CDATA[Dermatoscope benefits]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11656</guid>

					<description><![CDATA[<p>The dermatoscopic appearance of scalp tumors, especially melanocytic scalp lesions, differs from that on other body areas.</p>
<p>The post <a href="https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/">The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6abfd9861b029"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<ul class="authors">
<li><span class="name">Hatice Gamze Demirdag</span><span class="affiliation">Acıbadem İzmir Kent Hospital, Department of Dermatology, İzmir, Turkiye</span></li>
<li><span class="name">Elif Demirci Saadet</span><span class="affiliation">Atılım University School of Medicine, Medicana International Ankara Hospital, Department of Dermatology, Ankara, Turkiye</span></li>
</ul>
<h3 class="_label"><strong>Abstract</strong></h3>
<p><strong>Introduction: </strong>The dermatoscopic appearance of scalp tumors, especially melanocytic scalp lesions, differs from that on other body areas. Few studies have revealed the dermatoscopic characteristics of scalp nevi.</p>
<p><strong>Objectives:</strong> This study aimed to establish the clinical and dermatoscopic features of scalp nevi in adults and to compare dermatoscopic patterns according to the demographic and clinical features.</p>
<p><strong>Methods:</strong> This prospective study included 129 adult patients with 253 nevi. Demographic data of patients, clinical characteristics, and dermatoscopic features were recorded and compared.</p>
<p>To read more on this article please <a href="https://dpcj.org/index.php/dpc/article/view/6726" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<p>The post <a href="https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/">The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dermlite Lumio: Advanced Skin Examination Made Simple </title>
		<link>https://molemaxsystems.com/https-molemaxsystems-com-dermlite-lumio-advanced-skin-examination/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Sun, 16 Aug 2026 08:47:19 +0000</pubDate>
				<category><![CDATA[Digital Dermoscopy & Skin Imaging]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11254</guid>

					<description><![CDATA[<p>Skin cancer is one of the most common cancers globally, with melanoma alone responsible for the majority of skin cancer-related deaths worldwide. Early and accurate detection remains the most effective...</p>
<p>The post <a href="https://molemaxsystems.com/https-molemaxsystems-com-dermlite-lumio-advanced-skin-examination/">Dermlite Lumio: Advanced Skin Examination Made Simple </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Skin cancer is one of the most common cancers globally, with melanoma alone responsible for the majority of skin cancer-related deaths worldwide. Early and accurate detection remains the most effective strategy for improving patient outcomes, and the quality of clinical skin examination equipment plays a direct role in that process. For dermatologists, general practitioners, skin cancer clinics, and dermatology nurses, having a reliable, high-performance examination device is not optional, and it is a clinical necessity.&nbsp;</p>



<p class="wp-block-paragraph">The <a href="https://molemaxsystems.com/product/dermlite-lumio/" target="_blank" rel="noreferrer noopener">DermLite Lumio</a> is a portable, cross-polarised skin examination scope designed to meet the daily demands of modern dermatological practice. With a large 75 mm lens, 40 bright white LEDs, and cross-polarisation technology, it delivers clear, consistent visualisation of skin lesions and subsurface structures across a wide range of clinical applications. This article provides a comprehensive overview of the DermLite Lumio, its features, clinical applications, comparative advantages, and why it is a trusted choice for healthcare professionals supported by <a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">MoleMax Systems</a>.&nbsp;</p>



<h2 class="wp-block-heading"><strong>What Is the DermLite Lumio?</strong>&nbsp;</h2>



<p class="wp-block-paragraph">The <a href="https://molemaxsystems.com/product/dermlite-lumio/" target="_blank" rel="noreferrer noopener">DermLite Lumio</a> is a handheld skin examination scope built for dermatologists, dermatology nurses, general practitioners, and skin cancer clinicians who require consistent, high-quality visualisation during both routine and specialised skin assessments.&nbsp;</p>



<p class="wp-block-paragraph">Unlike standard handheld <a href="https://molemaxsystems.com/product-category/dermatoscopes/" target="_blank" rel="noreferrer noopener">dermatoscopes</a> designed primarily for individual lesion assessment, the DermLite Lumio is built around a large 75 mm aspheric lens with 2x magnification. This wide-field design provides a significantly broader viewing area, allowing clinicians to assess larger skin regions in a single examination pass. This is particularly valuable in high-volume screening environments where speed and thoroughness must be balanced.&nbsp;</p>



<p class="wp-block-paragraph">The device incorporates 40 bright white LEDs arranged to provide even, shadow-free illumination across the entire examination field. Combined with cross-polarisation technology, this eliminates surface reflection and glare, enabling detailed visualisation of subsurface skin structures without the need for immersion fluid or physical contact with the skin surface.&nbsp;</p>



<p class="wp-block-paragraph">The DermLite Lumio is battery-powered, lightweight, and compact, making it well suited for fixed clinic use, ward rounds, domiciliary visits, and mobile practitioners working across multiple care settings. Its design prioritises ease of use without compromising clinical performance.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Key Features of the DermLite Lumio</strong>&nbsp;</h2>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-1024x683.jpg" alt="DermLite DL5 Drmatoscope Eyepiece" class="wp-image-3567" srcset="https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-1024x683.jpg 1024w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-600x400.jpg 600w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-400x267.jpg 400w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-300x200.jpg 300w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-768x512.jpg 768w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-1536x1024.jpg 1536w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-2048x1365.jpg 2048w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-75x50.jpg 75w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-120x80.jpg 120w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-394x263.jpg 394w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-915x610.jpg 915w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-1240x827.jpg 1240w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-1620x1080.jpg 1620w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-90x60.jpg 90w, https://molemaxsystems.com/wp-content/uploads/2022/10/DL5-EP_straight-135x90.jpg 135w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">DermLite DL5 Drmatoscope Eyepiece</figcaption></figure>



<p class="wp-block-paragraph"><strong>Cross-Polarised Illumination</strong>: Cross-polarisation is the defining technical feature of the DermLite Lumio. By filtering light at perpendicular angles, the device suppresses surface reflection and allows clinicians to examine subsurface structures such as pigment networks, vascular patterns, regression structures, and follicular openings with clarity that is impossible under standard white light. This eliminates the need for immersion gel or fluid contact, improving examination hygiene and patient comfort.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Large 75 mm Aspheric Lens:</strong> The 75 mm wide-field lens is considerably larger than the typical 20-30 mm viewing area of conventional handheld dermatoscopes. This broader field of view reduces the number of repositioning steps required during each examination, supporting faster assessments and more systematic coverage of the skin surface. The aspheric design minimises optical distortion at the edges of the viewing field, maintaining image quality across the full examination area.&nbsp;</p>



<p class="wp-block-paragraph"><strong>40 Bright White LEDs</strong>: Forty LEDs are arranged to deliver even, consistent illumination without hot spots, shadows, or colour variation. Uniform illumination is critical for accurate colour assessment of pigmented lesions and for reliable identification of vascular structures. The LED array is designed for longevity, maintaining consistent light output across thousands of examination cycles.&nbsp;</p>



<p class="wp-block-paragraph"><strong>No Immersion Fluid Required:</strong> Cross-polarisation technology removes the requirement for immersion gel or fluid contact during examination. This simplifies the examination process, reduces consumable costs, and improves the patient experience by eliminating a step that many patients find uncomfortable.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Battery-Powered Portability</strong>: The DermLite Lumio operates on batteries, removing dependence on power outlets and making it genuinely portable across different clinical environments. Battery life is designed to support a full clinical day of examinations without interruption.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Ergonomic Design:</strong> The balanced, lightweight body reduces hand and wrist fatigue during extended examination sessions. The grip and button placement are designed to support one-handed operation, allowing the clinician to maintain patient positioning with the other hand throughout the examination.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Clinical Applications of the DermLite Lumio</strong>&nbsp;</h2>



<p class="wp-block-paragraph">The DermLite Lumio is designed as a versatile clinical tool that supports a broad range of dermatological examination needs rather than a single-purpose device.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Pigmented Lesion Assessment</strong>: Cross-polarised illumination enables clear visualisation of pigment distribution, border regularity, and internal structural features of pigmented lesions including melanocytic naevi, seborrhoeic keratoses, and suspected melanoma. The ability to assess pigment network architecture and atypical vascular patterns under polarised light supports more informed clinical decision-making about which lesions require further investigation or biopsy.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Skin Cancer Screening Support:</strong> The DermLite Lumio supports systematic skin cancer screening workflows where rapid examination of multiple lesions across large body surface areas is required. The wide-field lens reduces examination time per patient, while polarised illumination improves the detection of subtle features that may be missed under naked-eye examination. When used alongside integrated digital imaging platforms such as those offered by <a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">MoleMax Systems</a>, the DermLite Lumio contributes to a comprehensive early detection and monitoring workflow.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Hair Follicle and Scalp Examination</strong>: The consistent, wide-field illumination of the DermLite Lumio makes it effective for examining hair follicle density, follicular openings, perifollicular scaling, and scalp vascularity. It supports assessment of conditions including androgenetic alopecia, alopecia areata, folliculitis, and seborrhoeic dermatitis.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Vascular Structure Visualisation:</strong> Cross-polarised LED illumination enhances visualisation of subsurface vascular patterns including telangiectasias, arborising vessels, dotted vessels, and milky-red areas. These vascular features are diagnostically significant across a range of conditions including basal cell carcinoma, rosacea, and port wine stains.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Varicose Vein and Superficial Vascular Assessment</strong>: The large lens and even LED illumination support assessment of varicose veins, reticular veins, and spider telangiectasias, particularly useful in phlebology clinics and vascular dermatology settings where systematic mapping of superficial vessels is required.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Inflammatory and General Dermatological Conditions:</strong> Conditions including psoriasis, eczema, lichen planus, pityriasis rosea, and other inflammatory dermatoses benefit from enhanced illumination and magnification during clinical assessment. The wide-field view allows clinicians to assess the distribution and character of lesions across larger skin areas in a single examination step.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Wound and Ulcer Assessment</strong>: The DermLite Lumio&#8217;s consistent illumination supports clinical assessment of wound margins, granulation tissue, and early signs of infection in chronic wound management settings.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Benefits of Using DermLite Lumio in Clinical Practice</strong>&nbsp;</h2>



<p class="wp-block-paragraph"><strong>Faster and More Systematic Assessments:</strong> The large 75 mm field of view reduces repositioning steps and supports faster, more systematic skin examination. In busy skin cancer clinics and general practice settings, this translates to improved patient throughput without compromising examination quality.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Enhanced Diagnostic Visibility</strong>: Cross-polarised illumination consistently reveals subsurface detail that is invisible under standard white light or naked-eye examination. Clinicians benefit from greater confidence in identifying lesion features that influence clinical decision-making, including decisions about biopsy, excision, or monitoring.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Improved Patient Comfort and Experience:</strong> Examinations are faster, and the absence of immersion fluid makes them more comfortable. Patients benefit from shorter examination times and a cleaner, less invasive examination process. This is particularly valuable in paediatric dermatology and for patients with sensitive skin conditions.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Reliable Performance Across High-Volume Workloads</strong>: The DermLite Lumio is designed for repeated daily use. Its LED array maintains consistent light output, its battery supports full-day operation, and its ergonomic design reduces the physical strain associated with high-volume examination workloads.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Accessible for All Clinical Levels:</strong> The DermLite Lumio&#8217;s straightforward operation makes it effective for dermatology nurses, general practitioners, registrars, and other team members without specialised dermoscopy training. This broadens its utility across multidisciplinary clinical teams and supports consistent examination quality at all levels of clinical seniority.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Cost-Effective Clinical Investment</strong>: Compared with full digital imaging systems, the DermLite Lumio represents a cost-effective entry point into enhanced skin examination capability. For clinics building their dermatology equipment portfolio, it provides immediate diagnostic value while integrating naturally with more advanced systems as the practice grows.&nbsp;</p>
<p>The post <a href="https://molemaxsystems.com/https-molemaxsystems-com-dermlite-lumio-advanced-skin-examination/">Dermlite Lumio: Advanced Skin Examination Made Simple </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
